609 related articles for article (PubMed ID: 11120969)
1. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
2. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
3. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Bermudez LE; Kolonoski P; Petrofsky M; Wu M; Inderlied CB; Young LS
J Infect Dis; 2003 Jun; 187(12):1977-80. PubMed ID: 12792877
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
[TBL] [Abstract][Full Text] [Related]
5. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
[TBL] [Abstract][Full Text] [Related]
6. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
[TBL] [Abstract][Full Text] [Related]
7. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
Bermudez LE; Kolonoski P; Wu M; Aralar PA; Inderlied CB; Young LS
Antimicrob Agents Chemother; 1999 Aug; 43(8):1870-4. PubMed ID: 10428905
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.
Bermudez LE; Petrofsky M; Inderlied CB; Young LS
J Antimicrob Chemother; 1995 Oct; 36(4):641-6. PubMed ID: 8591938
[TBL] [Abstract][Full Text] [Related]
12. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
[TBL] [Abstract][Full Text] [Related]
13. Electron microscopic analysis of Mycobacterium avium complex isolates exposed to ciprofloxacin, rifabutin, ethambutol and clarithromycin.
Reisner BS; Woods GL; Popov VL
Int J Tuberc Lung Dis; 1997 Jun; 1(3):270-5. PubMed ID: 9432376
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
Deshpande D; Gumbo T
Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
[TBL] [Abstract][Full Text] [Related]
15. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
Saito H; Sato K
Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522
[TBL] [Abstract][Full Text] [Related]
16. A 'shock and awe' thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium-intracellulare complex disease.
Srivastava S; Deshpande D; Sherman CM; Gumbo T
J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i43-i47. PubMed ID: 28922810
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.
Bermudez LE; Reynolds R; Kolonoski P; Aralar P; Inderlied CB; Young LS
Antimicrob Agents Chemother; 2003 Aug; 47(8):2685-7. PubMed ID: 12878542
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
Griffith DE; Brown BA; Girard WM; Griffith BE; Couch LA; Wallace RJ
Clin Infect Dis; 2001 Jun; 32(11):1547-53. PubMed ID: 11340525
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
[TBL] [Abstract][Full Text] [Related]
20. MAC management.
PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
